Scandi Standard AB (publ) (STO:SCST)

Sweden flag Sweden · Delayed Price · Currency is SEK
94.50
-0.30 (-0.32%)
Aug 1, 2025, 5:29 PM CET
-0.32%
Market Cap6.17B
Revenue (ttm)13.44B
Net Income (ttm)285.00M
Shares Out65.33M
EPS (ttm)4.35
PE Ratio21.72
Forward PE18.27
Dividend2.50 (2.64%)
Ex-Dividend DateSep 18, 2025
Volume91,341
Average Volume66,873
Open94.90
Previous Close94.80
Day's Range94.00 - 95.70
52-Week Range74.60 - 105.00
Beta0.41
RSI46.54
Earnings DateJul 17, 2025

About CTI BioPharma

Scandi Standard AB (publ) produces and sells chilled, frozen, and ready-to-eat chicken products in Sweden, Norway, Ireland, Denmark, Finland, Germany, the United Kingdom, rest of Europe, and internationally. It operates through Ready-to-Cook, Ready-to-Eat, and Other segments. The company offers ready-to-cook, ready-to-eat, and other products under the Kronfågel, Ivars, Vitafågeln, Bosarp, Danpo, BornholmerHanen, and Den Stolte Hane, as well as Manor Farm brand names. It is also involved in production and sale of eggs; bird breeding, feed, and h... [Read more]

Founded 2013
Employees 3,346
Stock Exchange Nasdaq Stockholm
Ticker Symbol SCST
Full Company Profile

Financial Performance

In 2024, Scandi Standard AB's revenue was 13.03 billion, an increase of 0.08% compared to the previous year's 13.02 billion. Earnings were 275.00 million, an increase of 2.23%.

Financial Statements

News

Scandi Standard AB (FRA:0SL) Q4 2024 Earnings Call Highlights: Record Sales Growth and ...

Scandi Standard AB (FRA:0SL) Q4 2024 Earnings Call Highlights: Record Sales Growth and Strategic Expansions

6 months ago - GuruFocus